Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 6 NIH 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Somatostatinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Insulinoma 1 Immunoblastic Lymphadenopathy 1 Glucagonoma 1 Glioma 1

Interventions

Ifosfamide 18 Doxorubicin 18 Filgrastim 16 Radiotherapy 12 Vincristine 10 Cyclophosphamide 10 Cisplatin 9 Etoposide 8 Trabectedin 7 Granulocyte Colony-Stimulating Factor 7 Gene Expression Profiling 7 Polymerase Chain Reaction 6 Dactinomycin 6 sargramostim 5 etoposide phosphate 5 Paclitaxel 5 Mesna 4 Chemotherapy, Adjuvant 4 Brachytherapy 4 pegfilgrastim 3 Topotecan 3 Microarray Analysis 3 Irinotecan 3 Immunohistochemistry 3 Gemcitabine 3 Dexrazoxane 3 Base Sequence 3 olaparib 2 brostallicin 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡